NAD Supplementation to Prevent Progressive Neurological Disease in Ataxia Telangiectasia
Clinical trial NCT04870866 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04870866
- Sponsor
- University Hospital, Akershus
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-05
- Primary completion
- 2024-09-03
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.